Edition:
United Kingdom

Athenex Inc (ATNX.OQ)

ATNX.OQ on NASDAQ Stock Exchange Global Select Market

18.00USD
25 Jun 2019
Change (% chg)

$0.06 (+0.33%)
Prev Close
$17.94
Open
$18.21
Day's High
$18.25
Day's Low
$17.90
Volume
175,754
Avg. Vol
154,419
52-wk High
$20.90
52-wk Low
$9.38

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Johnson Lau

58 2011 Chief Executive Officer and Chairman of the Board

Randoll Sze

38 2018 Chief Financial Officer

William Zuo

56 1995 President, Polymed Therapeutic

Jeffrey Yordon

70 2017 Chief Operating Officer and President, Athenex Pharmaceutical Division

Rudolf Kwan

66 2014 Chief Medical Officer